drugset / Trial / NCT04189198

A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block

NCT04189198

Phase 1 Completed 60 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindHealth-services research

Summary

Effect of 2%Articaine versus 5%bupivacaine in pt undergoing short duration surgery in upper limb

Timeline

Start
2019-12-30
Primary completion
2020-03-22
Completion
2020-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 2 % Other
Subject Articaine Other / unclassified 30 ml Other
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 30 ml Other

Indications

No indication recorded.